Download PDFPDF
Review: cardioselective β1 blockers given for 3 days to 4 weeks do not reduce respiratory function in reactive airway disease
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address